CYCLERION THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $825.00K.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $1.83M.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $1.95M.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $6.00K, a 99.98% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $1.95M.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2021 was $30.50M, a 25.79% increase from fiscal 2020.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $24.25M, a 85.27% decline from fiscal 2019.
- CYCLERION THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2019 was $164.62M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $825.00K 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $2.08M S-4/A · filed 2026-07-22 | |
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $1.95M 10-K/A · filed 2025-11-12 | |
| 2023-06-30 | $1.95M 10-Q · filed 2024-11-14 | |
| 2021-12-31 | $30.50M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $30.50M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $24.25M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $24.25M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $164.62M 10-K · filed 2021-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2019-06-30 | $164.62M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |